761 related articles for article (PubMed ID: 31010136)
1. Tear Proteomics Approach to Monitoring Sjögren Syndrome or Dry Eye Disease.
Kuo MT; Fang PC; Chao TL; Chen A; Lai YH; Huang YT; Tseng CY
Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31010136
[TBL] [Abstract][Full Text] [Related]
2. Tear Proteomics Approach to Distinguishing Primary from Secondary Sjögren's Syndrome for Dry Eye Patients with Long-Term Instillation of Eyedrops.
Hsiao YT; Huang YT; Yu HJ; Fang PC; Kuo MT
Int J Mol Sci; 2022 Dec; 23(23):. PubMed ID: 36499565
[TBL] [Abstract][Full Text] [Related]
3. Abnormal protein profiles in tears with dry eye syndrome.
Ohashi Y; Ishida R; Kojima T; Goto E; Matsumoto Y; Watanabe K; Ishida N; Nakata K; Takeuchi T; Tsubota K
Am J Ophthalmol; 2003 Aug; 136(2):291-9. PubMed ID: 12888052
[TBL] [Abstract][Full Text] [Related]
4. Discovery and Verification of Sjögren's Syndrome Protein Biomarkers in Tears by Targeted LC-MRM.
Lépine M; Robert MC; Sleno L
J Proteome Res; 2024 Jun; 23(6):2219-2229. PubMed ID: 38682820
[TBL] [Abstract][Full Text] [Related]
5. Proteomic analysis revealed the altered tear protein profile in a rabbit model of Sjögren's syndrome-associated dry eye.
Zhou L; Wei R; Zhao P; Koh SK; Beuerman RW; Ding C
Proteomics; 2013 Aug; 13(16):2469-81. PubMed ID: 23733261
[TBL] [Abstract][Full Text] [Related]
6. The Use of Conjunctival Staining to Measure Ocular Surface Inflammation in Patients With Dry Eye.
Yang S; Lee HJ; Kim DY; Shin S; Barabino S; Chung SH
Cornea; 2019 Jun; 38(6):698-705. PubMed ID: 30844839
[TBL] [Abstract][Full Text] [Related]
7. Differential Diagnosis of Sjögren Versus Non-Sjögren Dry Eye Through Tear Film Biomarkers.
Akpek EK; Wu HY; Karakus S; Zhang Q; Masli S
Cornea; 2020 Aug; 39(8):991-997. PubMed ID: 32195754
[TBL] [Abstract][Full Text] [Related]
8. Tear Proteomics Study of Dry Eye Disease: Which Eye Do You Adopt as the Representative Eye for the Study?
Kuo MT; Fang PC; Kuo SF; Chen A; Huang YT
Int J Mol Sci; 2021 Jan; 22(1):. PubMed ID: 33401599
[TBL] [Abstract][Full Text] [Related]
9. Tear lipocalin and lysozyme in Sjögren and non-Sjögren dry eye.
Caffery B; Joyce E; Boone A; Slomovic A; Simpson T; Jones L; Senchyna M
Optom Vis Sci; 2008 Aug; 85(8):661-7. PubMed ID: 18677232
[TBL] [Abstract][Full Text] [Related]
10. Analysis of tear cytokines and clinical correlations in Sjögren syndrome dry eye patients and non-Sjögren syndrome dry eye patients.
Lee SY; Han SJ; Nam SM; Yoon SC; Ahn JM; Kim TI; Kim EK; Seo KY
Am J Ophthalmol; 2013 Aug; 156(2):247-253.e1. PubMed ID: 23752063
[TBL] [Abstract][Full Text] [Related]
11. Analysis of Th17-associated cytokines and clinical correlations in patients with dry eye disease.
Liu R; Gao C; Chen H; Li Y; Jin Y; Qi H
PLoS One; 2017; 12(4):e0173301. PubMed ID: 28379971
[TBL] [Abstract][Full Text] [Related]
12. Proteomic analysis of human lacrimal and tear fluid in dry eye disease.
Jung JH; Ji YW; Hwang HS; Oh JW; Kim HC; Lee HK; Kim KP
Sci Rep; 2017 Oct; 7(1):13363. PubMed ID: 29042648
[TBL] [Abstract][Full Text] [Related]
13. Ocular surface damage and tear lactoferrin in dry eye syndrome.
Danjo Y; Lee M; Horimoto K; Hamano T
Acta Ophthalmol (Copenh); 1994 Aug; 72(4):433-7. PubMed ID: 7825407
[TBL] [Abstract][Full Text] [Related]
14. Association of IL-21 cytokine with severity of primary Sjögren syndrome dry eye.
Lim SA; Nam DH; Lee JH; Kwok SK; Park SH; Chung SH
Cornea; 2015 Mar; 34(3):248-52. PubMed ID: 25603233
[TBL] [Abstract][Full Text] [Related]
15. Tear evaporation rates in Sjögren syndrome and non-Sjögren dry eye patients.
Goto E; Matsumoto Y; Kamoi M; Endo K; Ishida R; Dogru M; Kaido M; Kojima T; Tsubota K
Am J Ophthalmol; 2007 Jul; 144(1):81-85. PubMed ID: 17509507
[TBL] [Abstract][Full Text] [Related]
16. Tear proteomics in dry eye disease.
Kannan R; Das S; Shetty R; Zhou L; Ghosh A; Deshpande V
Indian J Ophthalmol; 2023 Apr; 71(4):1203-1214. PubMed ID: 37026251
[TBL] [Abstract][Full Text] [Related]
17. Tear Osmolarity and Matrix Metallopeptidase-9 in Dry Eye Associated with Sjögren's Syndrome.
Kook KY; Jin R; Li L; Yoon HJ; Yoon KC
Korean J Ophthalmol; 2020 Jun; 34(3):179-186. PubMed ID: 32495525
[TBL] [Abstract][Full Text] [Related]
18. Pro- and anti-inflammatory forms of interleukin-1 in the tear fluid and conjunctiva of patients with dry-eye disease.
Solomon A; Dursun D; Liu Z; Xie Y; Macri A; Pflugfelder SC
Invest Ophthalmol Vis Sci; 2001 Sep; 42(10):2283-92. PubMed ID: 11527941
[TBL] [Abstract][Full Text] [Related]
19. Epidermal Fatty Acid-Binding Protein: A Novel Marker in the Diagnosis of Dry Eye Disease in Sjögren Syndrome.
Shinzawa M; Dogru M; Den S; Ichijima T; Higa K; Kojima T; Seta N; Nomura T; Tsubota K; Shimazaki J
Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30400384
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-6 and tumor necrosis factor-alpha levels in tears of patients with dry eye syndrome.
Yoon KC; Jeong IY; Park YG; Yang SY
Cornea; 2007 May; 26(4):431-7. PubMed ID: 17457192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
